SEP 14, 2019 3:20 PM PDT

Why TB and HIV Occur Together So Often

WRITTEN BY: Carmen Leitch

Tuberculosis (TB) is among the world’s leading causes of death and is the primary cause of death in people who are HIV-positive. Among the 1.6 million people that died from TB in 2017, around 300,000 of them were HIV-positive, according to the World Health Organization. Researchers at the Texas Biomedical Research Institute have now learned more about why the two diseases are worse when they happen at once. This work, which has been reported in the Journal of Clinical Investigation, may help in the development of better treatments for those who are at risk.

Mycobacterium tuberculosis (Mtb) under a microscope. / Credit: Texas Biomedical Research Institute

"We were a little surprised at the extent of clarity in our data," noted Professor and Southwest National Primate Research Center Director Deepak Kaushal. "I am actually very excited to move forward trying different treatment approaches on co-infected monkeys."

TB is a bacterial infection caused by Mycobacterium tuberculosis and can spread when an infected person coughs or sneezes and another person breathes that air. TB is more likely to happen in people with weak immune systems, like HIV patients; specifically, HIV targets a type of immune cell called CD4+ cells. This new work indicates that other factors are also at work.

In this study, the scientists used a rhesus macaque model of HIV to show that chronic immune activation in the lung encourages or even causes the progression of the disease. When the body is fighting tough pathogens, immune pathways can produce too many inflammatory molecules like cytokines and chemokines.

"It's like all the taps and faucets in your house are turned on full blast all the time," explained Kaushal. "You are going to lose a lot of water. With this dysfunction, all cytokines ad chemokines are constantly being produced to the highest levels. This dysregulates the body's ability to fight off other infections."

Chronic immune activation happens even when people are controlling their HIV infection with antiretrovirals. Kaushal noted that "we need to develop approaches to target chronic immune activation," perhaps with a drug that would be an additional therapy along with ART.

Learn more about HIV as an inflammatory disorder from the video.

Sources: AAAS/Eurekalert! via Texas Biomedical Research Institute, Journal of Clinical Investigation

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 18, 2021
Cell & Molecular Biology
Learning More About the Molecular Basis of Appetite
OCT 18, 2021
Learning More About the Molecular Basis of Appetite
Neurons in the human brain play a crucial role in appetite, satiety, and metabolism. Research has revealed more about th ...
NOV 11, 2021
Immunology
Malaria Researchers Make a Surprising Antibody Find
NOV 11, 2021
Malaria Researchers Make a Surprising Antibody Find
Researchers looking into the immunology of malaria infections have made an unexpected find that could ultimately lead to ...
NOV 07, 2021
Cell & Molecular Biology
How Cells Use Messengers to Signal to One Another
NOV 07, 2021
How Cells Use Messengers to Signal to One Another
In recent years, researchers have discovered the importance of a kind of antenna that is found on most cells, a structur ...
NOV 23, 2021
Genetics & Genomics
Female Condors Reproduced Asexually Even Though Males Were Available
NOV 23, 2021
Female Condors Reproduced Asexually Even Though Males Were Available
Some animals can produce offspring from an unfertilized egg in an asexual reproduction process known as parthogenesis. W ...
NOV 25, 2021
Cell & Molecular Biology
Analyzing Cells With Virtual Reality
NOV 25, 2021
Analyzing Cells With Virtual Reality
Research tools that are used to analyze gene expression have gotten cheaper, faster, and incredibly complex. An entire h ...
DEC 08, 2021
Clinical & Molecular DX
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
DEC 08, 2021
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
By Julianne Davis - Technical Writer and Support Scientist at Biotium The Rise of the Lab-on-a-Chip With the advent of m ...
Loading Comments...